兴齐眼药涨2.06%，成交额3.67亿元，主力资金净流入3114.09万元

Group 1 - The core viewpoint of the news is that Xingqi Eye Pharmaceutical has shown fluctuations in its stock price and significant growth in revenue and profit for the year 2025 [1][2] Group 2 - As of January 28, Xingqi Eye Pharmaceutical's stock price increased by 2.06% to 72.70 CNY per share, with a total market capitalization of 17.915 billion CNY [1] - The company experienced a net inflow of main funds amounting to 31.14 million CNY, with large orders accounting for 26.03% of purchases [1] - Year-to-date, the stock price has risen by 3.43%, but it has seen a decline of 12.11% over the last five trading days [1] Group 3 - For the period from January to September 2025, Xingqi Eye Pharmaceutical achieved a revenue of 1.904 billion CNY, representing a year-on-year growth of 32.27%, and a net profit of 599 million CNY, which is a 105.98% increase [2] - The company has distributed a total of 1.166 billion CNY in dividends since its A-share listing, with 985 million CNY distributed over the past three years [2] - As of September 30, 2025, the number of shareholders increased by 16.85% to 54,100, while the average circulating shares per person decreased by 14.42% to 3,480 shares [2]